Meanwhile, upregulation of TLR2 signaling could activate the NLRP3 inflammasome and subsequent pro-inflammatory cytokine that results in progression to liver inflammation and hepatocyte injury in NASH (18, 66). This evidence concerns the gene TLR2 and metabolic dysfunction-associated steatohepatitis.